| Long-haul COVID-19 associated with chronic fatigue syndrome, breathing irregularities |
| Taiwan reviews myocarditis data, approves second doses of Pfizer-BioNTech COVID-19 vaccine for older children |
| STEMI mortality is on the decline, but certain patients still face an above-average risk |
| FDA clears AI-powered cardiac platform for pediatric patients |
| SAVR associated with 'substantial' survival rates |
| Questions mount as the new Omicron variant continues to spread |
| COVID-19 vaccine does not increase risk of heart attack or stroke in older adults, new study confirms |
| Cardiac rehabilitation benefits heart failure patients—but for how long? |
| How a high bleeding risk impacts outcomes for left main PCI patients |
| 58% of cardiologists have been named in a medical malpractice lawsuit |
| A new look at the links between obesity, type 2 diabetes and cancer |
| Generic statin options can save the US $11.9B per year |
| In-hospital mortality more common among COVID-19 patients with heart failure |
| DAPT after PCI can stop after 1 month, new research confirms |
| Certain patients with chronic kidney disease face a higher risk of death after TAVR |
| Aspirin use may increase your risk of heart failure |
| Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge |
| What we know about COVID-19 and cardiogenic shock |
| Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee |
| Data-driven ICM device management: EP’s ‘game-changer’ is building momentum |
| New study compares polymer and polymer-free drug-eluting stents after 3 years |
| Is depression a warning sign for heart failure? |
| Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents |
| Women are still experiencing COVID-related heart issues months after being diagnosed—and they may need extra help |
| FDA delays decision on Bristol Myers Squibb’s new heart disease drug |
| AFib patients able to safely transition from warfarin to a DOAC |
| Black, Hispanic AFib patients less likely to start anticoagulant therapy, new VA study finds |
| How a team-based approach affects care for high-risk PCI patients |
| Women much more likely to develop AFib after a breast cancer diagnosis |
| Empagliflozin provides consistent benefits for HFpEF patients |
| FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra |
| New study of more than 4.5M patients examines how blood pressure can impact the risk of dementia |
| PAD specialists announce new FDA clearance for image-guided atherectomy system |
| Patient frailty not a key factor when choosing between TAVR and SAVR |
| PCI and CABG for left main CAD associated with similar all-cause mortality rates |
| What new research tells us about TAVR and platelet-to-lymphocyte ratios |
| Stem cell therapy for heart failure lowers risk of adverse outcomes |
| Cardiologs puts its AI model up against the Apple Watch—and wins |
| European Society of Cardiology shares new guidance on COVID-related cardiovascular disease |
| Cardiologist urges Malaysia to end COVID-19 vaccination program—but fact-checking website says he used misleading statements |
| High-dose icosapent ethyl treatment makes minimal impact on non-hospitalized COVID-19 patients |
| Text message alert system for out-of-hospital cardiac arrests yields positive outcomes |
| American Heart Association responds to nomination of cardiologist Robert Califf for FDA commissioner |
| FDA clears ECG mapping system that tracks arrhythmia hot spots |
| New risk calculator detects TEER patients who may need to be readmitted for HF |
| New research details how drug and alcohol use increases a person's AFib risk |
| Biden expected to choose cardiologist who served under Obama as next FDA commissioner |
| Taiwan pauses second doses of Pfizer-BioNTech COVID-19 vaccine for older children due to myocarditis |
| Eating the right kind of fats can reduce a person's stroke risk |
| Texas cardiologist named in lawsuit says he will not be 'silenced by corporate bullies’ |
| How the presence of AFib can impact TAVR, SAVR outcomes |
| We may finally know why type 2 diabetes is associated with vascular damage |
| Mental stress–induced myocardial ischemia elevates risk of CV events |
| 'Remarkable' new findings suggest patients with diabetes should be screened for AFib |
| New survey examines the biggest issues impacting care for CAD, PAD patients |
| Combined genetic testing for cardiomyopathies and arrhythmias yields positive results |
| Life expectancy lower among SAVR patients than the general public |
| This is when you should sleep if you want to limit your risk of heart disease |
| Esteemed cardiologist dies unexpectedly—was known for his positive influence inside and outside the hospital |
| Policy experts call for renewed focus on cardiovascular disease, public health as COVID-19 crisis shows signs of improvement |
| Hispanic PAD patients often face longer hospitalizations, higher costs |
| These aerobic exercises can help lower your blood pressure |
| Early epinephrine treatment during cardiac arrest increases chance of a good recovery |
| ‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS |
| TMVR with transfemoral access a 'promising option,’ early data suggest |
| Philips enters agreement to acquire Cardiologs |
| Some cancer immunotherapies may increase the risk of myocarditis |
| Tracking sac regression after endovascular aneurysm repair for AAA |
| Ohio State cardiologists first in US to perform new heart failure treatment—patient feels ‘100% better’ |
| 5 years later, TAVR still delivering strong results for intermediate-risk patients |
| Icosapent ethyl lowers risk of ischemic events in CABG patients |
| TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms |
| Mild COVID-19 infections not associated with long-term risk of heart damage |
| Patients amenable to interventional procedure for lowering blood pressure |
| CABG still the ‘treatment of choice’ for patients with complex three-vessel CAD |
| CMS finalizes COVID-19 vaccine mandate for healthcare workers, requiring full vaccination by Jan. 4 |
| Sacubitril/valsartan no better than valsartan alone for advanced heart failure |
| The Biden administration just made it easier to repair medical devices—and imaging specialists are concerned |
| Acquisition Insights |
| Disabilities fairly common among adults with congenital heart defects |
| CMS sets payment rate for HeartFlow’s FFR-CT solution in 2022 Medicare Physician Fee Schedule |
| Vascular surgeons playing a key role as consultants in today’s trauma centers |
| Using pulmonary artery pressure monitoring to manage obese HF patients leads to strong outcomes |
| LAAC reduces stroke risk among patients with HCM and AFib |
| CMS finalizes 2022 Medicare Physician Fee Schedule—payments to cardiologists take a hit |
| Two-year outcomes highlight the value of TMVR for patients with severe MR |
| 'It does not need to be complicated': 10 steps to heart-healthy eating |
| FDA panel meets to review safety of endovascular graft device |
| STEMI patients with COVID-19 face an elevated risk of death |
| FDA announces Class I recall of battery packs for intra-aortic balloon pumps |
| New device could boost accuracy of noninvasive blood measurements |
| Tracking false-positive alerts among cardiac patients |
| DOACs outperform VKAs for stroke prevention in AFib patients |
